NeuroPace Reports First Quarter 2026 Financial Results and Raises Revenue Guidance
NeuroPace, Inc. announced its financial results for the first quarter of 2026, reporting total revenue of $22.1 million, a 20.1% year-over-year growth when excluding DIXI Medical. The revenue from the RNS System was $21.7 million for the quarter. The company also raised its revenue guidance for the year.
MOUNTAIN VIEW, Calif.–(BUSINESS WIRE)–NeuroPace, Inc. (Nasdaq: NPCE), a medical device company focused on transforming the lives of people living with epilepsy, today reported financial results for the first quarter ended March 31, 2026, and provided a corporate update. First Quarter 2026 Highlights Total revenue of $22.1 million in the quarter. Excluding DIXI Medical, total revenue of $22.0 million representing 20.1% year over year growth RNS System revenue of $21.7 million in the quarter, r